Clinical Trials Directory

Trials / Completed

CompletedNCT01197677

European CMR Registry

European Cardiovascular Magnetic Resonance Registry

Status
Completed
Phase
Study type
Observational
Enrollment
30,000 (actual)
Sponsor
Stiftung Institut fuer Herzinfarktforschung · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

1. The main aim of the first specific protocol initiated by the European CMR registry, suspected CAD, is to demonstrate that patients presenting for work up of suspected coronary artery disease, which have a completely normal CMR scan will have a low risk for cardiovascular events. 2. The main aim of the second specific protocol initiated by the European CMR registry, HCM-SCD, will be to evaluate CMR for risk stratification in hypertrophic cardiomyopathy(HCM). 3. This registry is sought to collect data on the general use of CMR in the European clinical practice, its safety and its therapeutic implications in a high number of cases to 1) substantiate the clinical yield of CMR and 2) to define additional clinical questions worth to be investigated in detail as additional specific protocols in the future.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2009-09-01
Completion
2013-10-01
First posted
2010-09-09
Last updated
2016-09-07

Locations

10 sites across 4 countries: Germany, Italy, Spain, Switzerland

Source: ClinicalTrials.gov record NCT01197677. Inclusion in this directory is not an endorsement.